Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Nano Lett ; 24(18): 5513-5520, 2024 May 08.
Article in English | MEDLINE | ID: mdl-38634689

ABSTRACT

P-type self-doping is known to hamper tin-based perovskites for developing high-performance solar cells by increasing the background current density and carrier recombination processes. In this work, we propose a gradient homojunction structure with germanium doping that generates an internal electric field across the perovskite film to deplete the charge carriers. This structure reduces the dark current density of perovskite by over 2 orders of magnitude and trap density by an order of magnitude. The resultant tin-based perovskite solar cells exhibit a higher power conversion efficiency of 13.3% and excellent stability, maintaining 95% and 85% of their initial efficiencies after 250 min of continuous illumination and 3800 h of storage, respectively. We reveal the homojunction formation mechanism using density functional theory calculations and molecular level characterizations. Our work provides a reliable strategy for controlling the spatial energy levels in tin perovskite films and offers insights into designing intriguing lead-free perovskite optoelectronics.

2.
Adv Mater ; 36(24): e2313524, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38453665

ABSTRACT

Crystallization orientation plays a crucial role in determining the performance and stability of perovskite solar cells (PVSCs), whereas effective strategies for realizing oriented perovskite crystallization is still lacking. Herein, a facile and efficient top-down strategy is reported to manipulate the crystallization orientation via treating perovskite wet film with propylamine chloride (PACl) before annealing. The PA+ ions tend to be adsorbed on the (001) facet of the perovskite surface, resulting in the reduced cleavage energy to induce (001) orientation-dominated growth of perovskite film and then reduce the temperature of phase transition, meanwhile, the penetrating Cl ions further regulate the crystallization process. As-prepared (001)-dominant perovskite films exhibit the ameliorative film homogeneity in terms of vertical and horizontal scale, leading to alleviated lattice mismatch and lowered defect density. The resultant PVSC devices deliver a champion power conversion efficiency (PCE) of 25.07% with enhanced stability, and the unencapsulated PVSC device maintains 95% of its initial PCE after 1000 h of operation at the maximum power point under simulated AM 1.5G illumination.

3.
Nat Commun ; 15(1): 1066, 2024 Feb 05.
Article in English | MEDLINE | ID: mdl-38316825

ABSTRACT

Presynthesized perovskite quantum dots are very promising for making films with different compositions, as they decouple crystallization and film-formation processes. However, fabricating large-area uniform films using perovskite quantum dots is still very challenging due to the complex fluidic dynamics of the solvents. Here, we report a robust film-formation approach using an environmental-friendly binary-solvent strategy. Nonbenzene solvents, n-octane and n-hexane, are mixed to manipulate the fluidic and evaporation dynamics of the perovskite quantum dot inks, resulting in balanced Marangoni flow, enhanced ink spreadability, and uniform solute-redistribution. We can therefore blade-coat large-area uniform perovskite films with different compositions using the same fabrication parameters. White and red perovskite light-emitting diodes incorporating blade-coated films exhibit a decent external quantum efficiency of 10.6% and 15.3% (0.04 cm2), and show a uniform emission up to 28 cm2. This work represents a significant step toward the application of perovskite light-emitting diodes in flat panel solid-state lighting.

4.
Adv Mater ; 36(8): e2309921, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38016083

ABSTRACT

Metal halide perovskite light-emitting diodes (PeLEDs) are attracting increasing attention due to their potential applications in flat panel lighting and displays. The solution process, large-area fabrication, and flexibility are attractive properties of PeLEDs over traditional inorganic LEDs. However, it is still very challenging to deposit uniform perovskite films on flexible substrates using a blade or slot-die coating, as the flexible substrate is not perfectly flat. Here, the inkjet printing technique is adopted, and the key challenges are overcome step-by-step in preparing large-area films on flexible substrates. Double-hole transporting layers are first used and a wetting interfacial layer to improve the surface wettability so that the printed perovskite droplets can form a continuous wet film. The fluidic and evaporation dynamics of the perovskite wet layer is manipulated to suppress the coffee ring effect by solvent engineering. Uniform perovskite films are obtained finally on flexible substrates with different perovskite compositions. The peak external quantum efficiency of the inkjet-printed PeLEDs reaches 14.3%. Large-area flexible PeLEDs (4 × 7 cm2 ) also show very uniform emission. This work represents a significant step toward real applications of large-area PeLEDs in flexible flat-panel lighting.

5.
Adv Mater ; 35(49): e2305946, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37547965

ABSTRACT

Perovskite/organic tandem solar cells (POTSCs) are gaining attention due to their easy fabrication, potential to surpass the S-Q limit, and superior flexibility. However, the low power conversion efficiencies (PCEs) of wide bandgap (Eg) perovskite solar cells (PVSCs) have hindered their development. This work presents a novel and effective mixed-cation passivation strategy (CE) to passivate various types of traps in wide-Eg perovskite. The complementary effect of 4-trifluoro phenethylammonium (CF3 -PEA+ , denoted as CA+ ) and ethylenediammonium (EDA2+ , denoted as EA2+ ) reduces both electron/hole defect densities and non-radiative recombination rate, resulting in a record open-circuit voltage (Voc ) of wide-Eg PVSCs (1.35 V) and a high fill factor (FF) of 83.29%. These improvements lead to a record PCE of 24.47% when applied to fabricated POTSCs, the highest PCE to date. Furthermore, unencapsulated POTSCs exhibit excellent photo and thermal stability, retaining over 90% of their initial PCE after maximum power point (MPP) tracking or exposure to 60 °C for 500 h. These findings imply that the synergic effect of surface passivators is a promising strategy to achieve high-efficiency and stable wide-Eg PVSCs and corresponding POTSCs.

6.
Adv Mater ; 34(49): e2207180, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36189875

ABSTRACT

The external quantum efficiency (EQE) of state-of-the-art planar-structure perovskite light-emitting diodes (PeLEDs) is mainly limited by the outcoupling efficiency, which is around 20% and decreases significantly with the perovskite thickness. Here, an approach to artificially form textured perovskite films to boost the outcoupling limit of the PeLEDs is reported. By manipulating the dwell time of antisolvents, the perovskite phase precipitation mechanism, film-forming process, and surface texture can be finely controlled. The film surface roughness can be tuned from 15.3 to 241 nm, with haze increasing accordingly from 6% to >90% for films with an average thickness of 1.5 µm. The light outcoupling limit increases accordingly from 11.7% for the flat PeLEDs to 26.5% for the textured PeLEDs due to photon scattering at the interface. Consequently, the EQE is boosted significantly from around 10% to 20.5% with an extraordinarily thick emissive layer of 1.5 µm. This study provides a novel way of forming light-extraction nanostructures for perovskite optoelectronic devices.

7.
Anticancer Drugs ; 33(2): 117-123, 2022 02 01.
Article in English | MEDLINE | ID: mdl-34561996

ABSTRACT

Platinum is reported to have adjuvant immune properties, whether oxaliplatin (OXA) could be utilized to synergize with anti-programmed cell death-1 (PD-1) antibody or anti-NKG2D (natural-killer group 2, member D) antibody is investigated. Subcutaneous A549 lung cancer and murine Lewis lung carcinoma (LLC) models were constructed, which were further intravenously injected with platinum-based drugs or concomitant administrated with anti-PD-1 antibody and or anti-NKG2D antibody. The tumor volume and the proportion of myeloid cells (CD45+CD11b+), CD3+T cells and NK (NK1.1+) cells were detected. The relative expression of chemokine (C-X-C motif) ligand 9 (CXCL9), CXCL10 and CXCL11 and C-X-C motif chemokine receptor 3 (CXCR3) was detected with the ELISA, western blot and flow cytometry. The three platinum drugs (cisplatin, DDP; carboplatin, CBP; OXA) showed similar effects to inhibit A549 tumor growth in immune-deficient mice. While OXA exhibited better antitumor efficacy in wild-type mice bearing LLC with downregulated myeloid cells proportion, upregulated concentration of CXCL9, CXCL10 and CXCL11, and upregulated proportion and CXCR3 expression on T cells and NK cells. OXA combined with anti-PD1 or anti-NKG2D synergistically improved tumor growth inhibition and survival. The combination of OXA to anti-PD1 and anti-NKG2D antibodies will provide the most appropriate treatment benefit. Oxaliplatin promotes T cells and NK cells infiltration through the CXCL9/10/11-CXCR3 axis to enhance anti-PD1 or anti-NKG2D immunotherapy in lung cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Chemokines, CXC/drug effects , Immune Checkpoint Inhibitors/pharmacology , Killer Cells, Natural/drug effects , Lung Neoplasms/drug therapy , Organoplatinum Compounds/pharmacology , A549 Cells , Animals , Antigens, Surface , Antineoplastic Agents/administration & dosage , Carboplatin/administration & dosage , Carboplatin/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Cisplatin/administration & dosage , Cisplatin/pharmacology , Drug Combinations , Humans , Immune Checkpoint Inhibitors/administration & dosage , Ligands , Lung Neoplasms/pathology , Male , Mice , Mice, Inbred C57BL , Myeloid Cells/drug effects , Organoplatinum Compounds/administration & dosage , Oxaliplatin/pharmacology , T-Lymphocytes , Tumor Burden/drug effects
8.
Tumour Biol ; 37(3): 3043-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26423399

ABSTRACT

Gastric cancer is one of the leading causes of cancer death worldwide. However, precise molecular mechanisms underlining its development are far from clear. We recently reported that PES1 promoted development of breast cancer and ovarian cancer as an oncogene. In this study, we reported that ablation of endogenous PES1 resulted in significant suppression of cell proliferation and growth and led to cell cycle arrest in G2 or G1 phase, respectively, in two gastric cancer cell lines (AGS and N87) in vitro. Meanwhile, silencing of PES1 obviously decreased expressions of cyclin D1, HIF-1α, and vascular endothelial growth factor (VEGF) expressions and increased p21WAF1 expression. Re-expression of PES1 in these two kinds of PES1 knockdown cells rescued these effects. In vivo, repression of endogenous PES1 expression suppressed gastric tumor growth in nude mice. In addition, 40.7 % (24/59) of gastric cancer tissues showed PES1 expression via immunohistochemical (IHC) staining. However, there were not any positive PES1 stainings in matched adjacent tissues. Our results demonstrated that repression of PES1 changed expressions of some cell proliferation- and angiogenesis-related genes and inhibited gastric cancer growth, and PES1 expression increased in gastric cancer tissues. These results suggest that PES1 may play an important role in development of gastric cancer. PES1 may be a potential target for gastric cancer therapy.


Subject(s)
Proteins/physiology , Stomach Neoplasms/pathology , Animals , Cell Line, Tumor , Cell Proliferation , Humans , Mice , Mice, Inbred BALB C , Proteins/analysis , RNA-Binding Proteins , Stomach Neoplasms/blood supply , Stomach Neoplasms/etiology
9.
IUBMB Life ; 65(12): 1017-25, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24376209

ABSTRACT

Estrogen exhibits mitogenic activity in early ovarian carcinogenesis and plays an important role in ovarian tumorigenesis. Due to the increased expression of ERα and decreased expression of the ERß, the ratio of ERα and ERß is markedly increased in ovarian cancer. We have recently reported that PES1 regulates the balance of ERα and ERß at the post-transcriptional level in breast cancer. Here, we report that PES1 inversely regulates the expression of ERα and ERß in addition to their transcriptional activities in epithelial ovarian cancer. We found that the ablation of PES1 resulted in the significant downregulation of ERα and estrogen-responsive genes such as cylin D1, HIF-1α and VEGF and the up-regulation of ERß and p21WAF1. Cell proliferation in both tested ovarian cell lines was markedly inhibited and cells were arrested in G2 after PES1 was ablated. Further analysis of clinical samples showed that expression of PES1 correlated positively with ERα expression and negatively with ERß expression. Our results demonstrate that PES1 may play important role in the progression of ovarian cancer by inversely regulating the ERα and ERß expression. PES1 may be a new target for ovarian cancer therapy.


Subject(s)
Estrogen Receptor alpha/genetics , Estrogen Receptor beta/genetics , Gene Expression Regulation, Neoplastic , Ovarian Neoplasms/metabolism , Proteins/physiology , Case-Control Studies , Cell Proliferation , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Female , HEK293 Cells , Humans , MCF-7 Cells , Ovarian Neoplasms/genetics , Ovary/metabolism , Ovary/pathology , RNA-Binding Proteins , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...